← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Iaso Therapeutics, Inc.
East Lansing, MI
$2,486,157
Total funding
4
Grants
Funding over time
peak $1.7M · FY2019–22$2M$1.5M$1M$500K$0
'19
'20
'21
'22
Funding mix
By agency
NSF$1,591,595 · 2
NIH$894,562 · 2
By mechanism
—$1,591,595 · 2
R43$894,562 · 2
Investigators at Iaso Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
SBIR Phase II: A Novel Bacteriophage Mutant as a Platform Carrier for Next Generation Vaccines$1,366,595
· FY2022 · TIP
Development of proprietary bacteriophage Qbeta as a vaccine carrier platform for anti-salmonella vaccine$300,000
R43 · FY2021 · AI
A Novel Vaccine Strategy to Target Breast Cancer Enabled by Proprietary Mutant Bacteriophage Qbeta-Tumor Antigen Conjugates$300,000
R43 · FY2020 · CA
Development of proprietary bacteriophage Qbeta as a vaccine carrier platform for anti-salmonella vaccine$294,562
R43 · FY2022 · AI
SBIR Phase I: Development of Bacteriophage Qbeta and Mutants as Carriers for Next Generation Vaccines$225,000
· FY2019 · TIP